Featured Research

from universities, journals, and other organizations

Clotting In Veins Close To Skin May Be Associated With More Dangerous Deep-vein Blood Clots

Date:
July 21, 2009
Source:
JAMA and Archives Journals
Summary:
About one-fourth of patients with superficial vein thrombosis -- clotting in blood vessels close to the skin -- also may have the life-threatening condition deep vein thrombosis, according to a new report.

About one-fourth of patients with superficial vein thrombosis—clotting in blood vessels close to the skin—also may have the life-threatening condition deep vein thrombosis, according to a report in the July issue of Archives of Dermatology, one of the JAMA/Archives journals.

"Superficial vein thrombosis is a common disease that most often affects the veins of the leg but can also be found in other locations," the authors write as background information in the article. Different risk factors have been reported, many of which are the same as risk factors for deep vein thrombosis—varicose veins, thrombophilia (a disorder in which the blood clots too easily), use of oral contraceptives, trauma, malignancy or a period of immobility. "In the past, not much interest has been focused on superficial vein thrombosis because of its generally benign course. However, recent investigations showed an unsuspected association of superficial vein thrombosis with deep vein thrombosis and thromboembolism [blockage of a blood vessel by a clot that has broken apart]."

Barbara Binder, M.D., of the Medical University of Graz, Austria, and colleagues studied 46 consecutive patients (32 women and 14 men) with superficial vein thrombosis between November 2006 and June 2007. All patients underwent color-coded duplex sonography, an imaging test, to confirm superficial vein thrombosis and exclude or detect deep vein thrombosis. Participants also reported their history of clotting events, use of oral contraceptives and compression stockings, any recent immobilization and active malignant disease. Laboratory tests included D-dimer levels, a measure of protein fragments that tends to be elevated in patients with deep vein thrombosis.

Deep vein thrombosis was detected in 24 percent of patients with superficial vein thrombosis and was usually asymptomatic. Deep vein thrombosis occurred in the same leg as superficial vein thrombosis in 73 percent of the patients, in the other leg in 9 percent and in both legs in 18 percent. "The calf muscle veins were most commonly involved," the authors write. "In all patients with deep vein thrombosis, the superficial vein thrombosis was located on the lower leg and the D-dimer findings were positive."

"Generally, superficial vein thrombosis is regarded as a condition with an uncomplicated course and usually is not considered to be a severe or life-threatening disease. However, the occurrence of concomitant deep vein thrombosis and/or pulmonary embolism [blood clot that travels to the lungs] may lead to severe complications," they continue. "The results of this study indicate that concurrent deep vein thrombosis is more likely when superficial vein thrombosis affects the lower leg. In these cases, the deep veins should be assessed by color-coded duplex sonography (from the inguinal [groin] region to the ankle) to exclude or confirm acute deep vein thrombosis."


Story Source:

The above story is based on materials provided by JAMA and Archives Journals. Note: Materials may be edited for content and length.


Journal Reference:

  1. Barbara Binder; Helmut Karl Lackner; Wolfgang Salmhofer; Susanne Kroemer; Jasmina Custovic; Rainer Hofmann-Wellenhof. Association Between Superficial Vein Thrombosis and Deep Vein Thrombosis of the Lower Extremities. Archives of Dermatology, 2009; [link]

Cite This Page:

JAMA and Archives Journals. "Clotting In Veins Close To Skin May Be Associated With More Dangerous Deep-vein Blood Clots." ScienceDaily. ScienceDaily, 21 July 2009. <www.sciencedaily.com/releases/2009/07/090720163553.htm>.
JAMA and Archives Journals. (2009, July 21). Clotting In Veins Close To Skin May Be Associated With More Dangerous Deep-vein Blood Clots. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2009/07/090720163553.htm
JAMA and Archives Journals. "Clotting In Veins Close To Skin May Be Associated With More Dangerous Deep-vein Blood Clots." ScienceDaily. www.sciencedaily.com/releases/2009/07/090720163553.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins